This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: Avidin Co. Ltd., Soneas Research Co. Ltd., Synaging Sas. Active years: 2019.
Company Filing History:
Years Active: 2019
Title: Thierry Pillot: Innovator in Pharmaceutical Chemistry
Introduction
Thierry Pillot is a notable inventor based in Crevic, France. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on enantiomers of 8-hydroxyquinoline derivatives. His research focuses on the synthesis and application of these compounds in medicinal and pharmaceutical compositions.
Latest Patents
Thierry Pillot holds a patent for "Enantiomers of 8-hydroxyquinoline derivatives and the synthesis thereof." This invention relates to novel enantiomer derivatives of 8-hydroxyquinoline with general formulas (I) and (II). The patent emphasizes the synthesis of these compounds and their pharmaceutically acceptable salts and metal complexes. The novel enantiomer derivatives are significant as they provide biological effects and characteristics that were previously only associated with racemic products. The invention also introduces a stereoselective synthesis method for preparing these enantiomers, which are suitable for treating various neuropsychiatric and neurologic diseases.
Career Highlights
Throughout his career, Thierry Pillot has worked with several companies, including Synaging SAS and Soneas Research Co. Ltd. His work has been instrumental in advancing the understanding and application of enantiomers in medical treatments.
Collaborations
Thierry has collaborated with notable professionals in his field, including István Kanizsai and László Puskás. Their joint efforts have contributed to the development of innovative solutions in pharmaceutical chemistry.
Conclusion
Thierry Pillot's contributions to the field of pharmaceutical chemistry, particularly through his patent on enantiomers of 8-hydroxyquinoline derivatives, highlight his role as an innovator. His work not only advances scientific knowledge but also has the potential to improve treatment options for various diseases.